Nebenwirkungen · Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka)
Lenalidomide Krka d.d. Novo mesto 2.5 mg hard capsules Lenalidomide Krka d.d. Novo mesto 5 mg hard capsules Lenalidomide Krka d.d. Novo mesto 7.5 mg hard capsules Lenalidomide Krka d.d. Novo mesto 10 mg hard capsules Lenalidomide Krka d.d. Novo mesto 15 mg hard capsules Lenalidomide Krka d.d. Novo mesto 20 mg hard capsules Lenalidomide Krka d.d. Novo mesto 25 mg hard capsules · Abschnitt 4.8 · PDF-Seite 27
HOS-148802 · Präparat HOS-099972
Uncommon Colitis, Caecitis Hepatobiliary Very common Common Disorders Alanine aminotransferase increased, Cholestasis◊, Hepatotoxicity, Aspartate aminotransferase increased Hepatocellular injury◊◊, Alanine aminotransferase increased, Common Abnormal liver function tests◊ Hepatocellular injury◊◊, Abnormal liver function tests◊, Hyperbilirubinaemia Uncommon Hepatic failure^ Uncommon Hepatic failure^ Skin and Very common Common Subcutaneous Rashes◊◊, Pruritus Rashes◊◊ Tissue Disorders Common Uncommon Urticaria, Hyperhidrosis, Dry skin, Skin Drug rash with eosinophilia and hyperpigmentation, Eczema, Erythema systemic symptoms◊◊
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2021-12-17T12:56:00Z · SHA-256 9b15721a878f6b48caf8691524d0cc634862d39053d4ce108521191ff1511e31 · Passage 2aefed7f92c7cf7925efd6776a5775e64dfed15d325bd6a9b57532a8a0ddc21e · Zeichen 20757–21918 im Abschnitt